Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.

Nanni O, Amadori D, De Censi A, Rocca A, Freschi A, Bologna A, Gianni L, Rosetti F, Amaducci L, Cavanna L, Foca F, Sarti S, Serra P, Valmorri L, Bruzzi P, Corradengo D, Gennari A; MYME investigators.

Breast Cancer Res Treat. 2019 Apr;174(2):433-442. doi: 10.1007/s10549-018-05070-2. Epub 2018 Dec 7.

PMID:
30536182
2.

Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM).

Gori S, Puglisi F, Cinquini M, Pappagallo G, Frassoldati A, Biganzoli L, Cortesi L, Fiorentino A, Angiolini C, Tinterri C, De Censi A, Levaggi A, Del Mastro L.

Eur J Cancer. 2018 Aug;99:9-19. doi: 10.1016/j.ejca.2018.04.006. Epub 2018 Jun 7. Review.

PMID:
29886394
3.

Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes.

Smith SG, Foy R, McGowan JA, Kobayashi LC, de Censi A, DeCensi A, Brown K, Side L, Cuzick J.

Br J Gen Pract. 2017 Jun;67(659):e414-e427. doi: 10.3399/bjgp17X689377. Epub 2017 Feb 13. Erratum in: Br J Gen Pract. 2018 Oct;68(675):468. DeCensi A [corrected to de Censi A].

4.

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Lambertini M, Ceppi M, Cognetti F, Cavazzini G, De Laurentiis M, De Placido S, Michelotti A, Bisagni G, Durando A, Valle E, Scotto T, De Censi A, Turletti A, Benasso M, Barni S, Montemurro F, Puglisi F, Levaggi A, Giraudi S, Bighin C, Bruzzi P, Del Mastro L; MIG and GIM study groups.

Eur J Cancer. 2017 Jan;71:34-42. doi: 10.1016/j.ejca.2016.10.030. Epub 2016 Dec 10.

PMID:
27951450
5.

Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies.

Gennari A, Costa M, Puntoni M, Paleari L, De Censi A, Sormani MP, Provinciali N, Bruzzi P.

Breast Cancer Res Treat. 2015 Apr;150(2):405-13. doi: 10.1007/s10549-015-3328-0. Epub 2015 Mar 6. Review.

PMID:
25744295
6.

Prevention of colorectal adenomas.

Principi M, De Censi A.

Colorectal Dis. 2015 Jan;17 Suppl 1:20-4. doi: 10.1111/codi.12817. No abstract available.

PMID:
25511857
7.

Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial.

Bonelli L, Puntoni M, Gatteschi B, Massa P, Missale G, Munizzi F, Turbino L, Villanacci V, De Censi A, Bruzzi P.

J Gastroenterol. 2013 Jun;48(6):698-705. doi: 10.1007/s00535-012-0691-z. Epub 2012 Oct 13.

PMID:
23065023
8.

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.

Rizzoli R, Body JJ, DeCensi A, Reginster JY, Piscitelli P, Brandi ML; European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO).

Osteoporos Int. 2012 Nov;23(11):2567-76. doi: 10.1007/s00198-011-1870-0. Epub 2012 Jan 20. Erratum in: Osteoporos Int. 2012 Nov;23(11):2577. De Censi, A [corrected to DeCensi, A].

PMID:
22270857
9.

Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.

Gennari A, Piccardo A, Altrinetti V, Corradengo D, Villavecchia G, De Censi A.

Curr Oncol Rep. 2012 Feb;14(1):20-6. doi: 10.1007/s11912-011-0210-z.

PMID:
22094933
10.

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

Haugan Moi LL, Hauglid Flågeng M, Gandini S, Guerrieri-Gonzaga A, Bonanni B, Lazzeroni M, Gjerde J, Lien EA, DeCensi A, Mellgren G.

Clin Cancer Res. 2010 Apr 1;16(7):2176-86. doi: 10.1158/1078-0432.CCR-09-1859. Epub 2010 Mar 23. Erratum in: Clin Cancer Res. 2010 Oct 15;16(20):5087. De Censi, Andrea [corrected to DeCensi, Andrea].

11.

Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies.

Sogno I, Venè R, Ferrari N, De Censi A, Imperatori A, Noonan DM, Tosetti F, Albini A.

Crit Rev Oncol Hematol. 2010 Jul;75(1):2-14. doi: 10.1016/j.critrevonc.2009.10.007. Epub 2010 Jan 19. Review.

PMID:
20034809
12.

Role of traditional and new biomarkers in breast carcinogenesis.

Macis D, Cazzaniga M, De Censi A, Bonanni B.

Ecancermedicalscience. 2009;3:157. doi: 10.3332/ecancer.2009.157. Epub 2009 Oct 29.

Supplemental Content

Loading ...
Support Center